Press Releases

WREXHAM, UK, 13 June 2023 – Ipsen today announced a £75 million investment in its…

SLOUGH, UK, 5th April 2023 – Ipsen is disappointed that the National Institute for Health…

Cabozantanib has been recommended by NICE as an option for treating advanced hepatocellular carcinoma (HCC),…

Dublin, Ireland, 25th/26th September 2022 Tánaiste joins Ipsen Ireland to launch upgraded manufacturing site in…

Ireland, May 2022 Blanchardstown-based, biopharmaceutical Ipsen has been announced overall Pharma Industry Company of the…

SLOUGH, UK, 21 March 2022 — Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment…

WREXHAM, UK, 24 February 2022 Today, Simon Hart MP, Secretary of State for Wales, visited…

Advanced kidney cancer patients in Scotland become amongst the first in world to access CABOMETYX®▼…